Interferon AlPha And C-Phycocyanin For The Treatment Of Autoimmune Diseases, Allergy And Cancer

The present invention consists of the combination of Interferon alpha and C-Phycocyanin (IFN-alpha/C-Phyco) for obtaining a pharmaceutical preparation for autoimmune disease, allergy and cancer treatments. The anti-inflammatory, immunomodulator, antioxidant, anti-viral, anti-proliferative and anti-t...

Full description

Saved in:
Bibliographic Details
Main Authors LOPEZ SAURA PEDRO ANTONIO, CERVANTES LLANOS MAJEL, PENTON ROL GISELLE, PENTON ARIAS EDUARDO, GUILLEN NIETO GERARDO ENRIQUE, GARCIA DEL BARCO HERRERA DIANA, VALENZUELA SILVA CARMEN MARIA
Format Patent
LanguageEnglish
Published 12.11.2009
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention consists of the combination of Interferon alpha and C-Phycocyanin (IFN-alpha/C-Phyco) for obtaining a pharmaceutical preparation for autoimmune disease, allergy and cancer treatments. The anti-inflammatory, immunomodulator, antioxidant, anti-viral, anti-proliferative and anti-tumoral effects, associated to the regulatory T cell inducer effect demonstrated in this invention is the rationale for the use of the IFN-alpha/C-Phyco combination in these diseases.
Bibliography:Application Number: US20060091776